Affiliation:
1. Department of Endocrinology, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, China
2. Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou 510000, China
Abstract
The rising prevalence of obesity has resulted in an increased demand for innovative and effective treatment strategies. Houttuynia cordata Thunb. (H. cordata) has demonstrated promising potential in preventing obesity. However, the mechanism underlying the anti-obesity effects of H. cordata and its bioactive component, sodium houttuybonate (SH), remains unclear. Our study reveals that SH treatment promotes the browning of inguinal white adipose tissue (iWAT) and prevents the obesity induced by a high-fat diet. SH significantly mitigates ferroptosis by upregulating glutathione peroxidase 4 (Gpx4) and decreasing malondialdehyde (MDA) levels, while also enhancing superoxide dismutase (SOD) levels. Furthermore, SH promotes the phosphorylation of AMP-activated protein kinase (AMPK), which subsequently increases the expression of nuclear factor erythroid 2-related factor 2 (NRF2) and heme oxygenase-1 (HO-1) in the iWAT. However, the effects of SH were attenuated by ML385, an Nrf2 inhibitor. Collectively, our findings suggest that SH induces iWAT browning and prevents diet-induced obesity primarily through the AMPK/NRF2/HO-1 pathway by inhibiting ferroptosis.
Funder
National Science Fund for Distinguished Young Scholars
Joint Funds of the National Natural Science Foundation of China
National Key Research and Development Project
Key-Area Clinical Research Program of Southern Medical University
National Natural Science Foundation of China
Science and Technology Planning Project of Shenzhen Municipality
Reference34 articles.
1. Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association;Poirier;Circulation,2021
2. Redefining Type 2 Diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’?;Astrup;Obes. Rev.,2000
3. Obesity and Nonalcoholic Fatty Liver Disease: From Pathophysiology to Therapeutics;Polyzos;Metabolism,2019
4. Obesity as a Major Risk Factor for Cancer;Silvestris;J. Obes.,2013
5. Obesity and Cancer Mechanisms: Cancer Metabolism;Hopkins;J. Clin. Oncol.,2016